Article section

Article title
Contributor
Abstract
About article
DOI
Citation style
Copyright
Open access
References
Research Article

Diagnosis of Bladder Cancer by Studying microRNA Gene Variations as a Molecular Genetic Marker

Authors

  • Sarah Salih Hasan Faculty of Medicine, Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences, Iraq

    sarahhasan121q@gmail.com

Abstract

Bladder cancer (BC) is one of the most prevalent malignancies worldwide, representing a significant public health burden with high rates of morbidity and mortality. Despite advances in diagnosis and treatment, survival rates for advanced bladder cancer remain suboptimal, highlighting the critical need for a deeper understanding of its pathogenesis and the identification of novel prognostic and therapeutic biomarkers. This study aims to elucidate the association between the miR-146a rs2910164 SNP and bladder cancer risk, as well as its potential impact on gene expression and clinical outcomes in an Iraqi cohort. The study involved a total of 160 participants, comprising 80 patients diagnosed with bladder cancer (case group) and 80 age- and gender-matched healthy individuals (control group). Genotyping was performed using Tetra-ARMS polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (RFLP) analysis. Gel electrophoresis analysis showed that the C allele was more frequent in cases than controls (68 vs. 34), with a significantly association (OR: 1.42, 95% CI: 0.90-2.24; p = 0.029). Conversely, the G allele, while slightly more common in controls (112 v. 106), demonstrated a lower association with cancer susceptibility. Our findings provide robust evidence for the role of the mRNA-seq-associated RNA (miR) 2910164 in bladder cancer, with distinct genotypic patterns and statistical significance between cases and controls.

Keywords:

Bladder Cancer Genetic Susceptibility Genotyping and Nf-Κb Pathway Inflammation Iraqi Population Mir-146a Rs2910164 Polymorphism Tetra-Arms Pcr

Article information

Journal

Journal of Medical Science, Biology, and Chemistry

Volume (Issue)

2(2), (2025)

Pages

15-21

Published

05-07-2025

How to Cite

Hasan, S. S. (2025). Diagnosis of Bladder Cancer by Studying microRNA Gene Variations as a Molecular Genetic Marker. Journal of Medical Science, Biology, and Chemistry, 2(2), 15-21. https://doi.org/10.69739/jmsbc.v2i2.645

References

Jazdzewski, K., Murray, E. L., Franssila, K., Jarzab, B., Schoenberg, D. R., & de la Chapelle, A. (2008). Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proceedings of the National Academy of Sciences, 105(20), 7269–7274. https://doi.org/10.1073/pnas.0802682105

Kamat, A. M., Hahn, N. M., Efstathiou, J. A., Lerner, S. P., Malmström, P. U., Choi, W., ... & Kassouf, W. (2016). Bladder cancer. The Lancet, 388(10061), 2796-2810.‏Kamat, A. M., Hahn, N. M., Efstathiou, J. A., Lerner, S. P., Malmström, P. U., Choi, W., Guo, C. C., Lotan, Y., & Kassouf, W. (2016). Bladder cancer. The Lancet, 388(10061), 2796–2810. https://doi.org/10.1016/S0140-6736(16)30512-8

Lenis, A. T., Lec, P. M., Chamie, K., & Bladder Cancer: A Review. (2020). Bladder cancer: A review. JAMA, 324(19), 1980–1991. https://doi.org/10.1001/jama.2020.17598

Li, L., Chen, X. P., & Li, Y. J. (2010). MicroRNA‐146a and human disease. Scandinavian Journal of Immunology, 71(4), 227–231. https://doi.org/10.1111/j.1365-3083.2010.02395.x

Nahid, M. A., Pauley, K. M., Satoh, M., & Chan, E. K. L. (2009). miR-146a is critical for endotoxin-induced tolerance: Implication in innate immunity. Journal of Biological Chemistry, 284(50), 34590–34599. https://doi.org/10.1074/jbc.M109.056317

Omar, N. S., & Ali, R. T. (2019). Dosimetric Analysis with Intensity-modulated Radiation Therapy for Central Nervous System Irradiation in Patients with Brain Cancer Compared with Three-dimensional Conformal Radiation Therapy Treatment. Polytechnic Journal, 9(2), 9.‏

Omar, N. S., Ahmed, F. K., Saleem, D. S., Shah, L. J. A., & Abbas, M. A. (2024). Influence of Maternal Body Mass Index on Fetal Ultrasound Biometry. Cihan University-Erbil Scientific Journal, 8(2), 93-98.‏

‏Ramkaran, P., Khan, S., Phulukdaree, A., Moodley, D., & Chuturgoon, A. A. (2013). miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. SpringerPlus, 2(1), 1–9. https://doi.org/10.1186/2193-1801-2-534

Ramkaran, P., Khan, S., Phulukdaree, A., Moodley, D., & Chuturgoon, A. A. (2014). miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell biochemistry and biophysics, 68, 259-266.

Rusca, N., & Monticelli, S. (2011). MiR‐146a in immunity and disease. Molecular Biology International, 2011, 437301. https://doi.org/10.4061/2011/437301

Saginala, K., Barsouk, A., Sukumar Aluru, J., Rawla, P., Padala, S. A., & Barsouk, A. (2020). Epidemiology of bladder cancer. Medical Sciences, 8(1), 15. https://doi.org/10.3390/medsci8010015

Sanli, O., Dobruch, J., Knowles, M. A., Burger, M., Alemozaffar, M., Nielsen, M. E., & Lotan, Y. (2017). Bladder cancer. Nature reviews Disease primers, 3(1), 1-19.‏Xie, W. Q., Tan, S. Y., & Wang, X. F. (2014). MiR-146a rs2910164 polymorphism increases risk of gastric cancer: a meta-analysis. World Journal of Gastroenterology: WJG, 20(41), 15440.‏

Xu, B., Feng, N. H., Li, P. C., Tao, J. H., Wu, D., Zhang, Z. Y., Li, K., & Zhang, Y. (2014). Association between the rs2910164 polymorphism in pre-miR-146a and cancer risk: An updated meta-analysis. Asian Pacific Journal of Cancer Prevention, 15(18), 7643–7649.

Downloads

Views

21

Downloads

7